Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Use of Letermovir for Salvage Therapy for Resistant Cytomegalovirus in a Pediatric Hematopoietic Stem Cell Transplant Recipient.

Kilgore JT, Becken B, Varga MG, Parikh S, Prasad V, Lugo D, Chang YC.

J Pediatric Infect Dis Soc. 2019 Jul 31. pii: piz050. doi: 10.1093/jpids/piz050. [Epub ahead of print]

PMID:
31362308
2.

Smoking, Helicobacter pylori serology, and gastric cancer risk in prospective studies from China, Japan, and Korea.

Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, Abnet CC, Yoo KY, Park SK, Kim J, Jee SH, Qiao YL, Shu XO, Waterboer T, Pawlita M, Epplein M.

Cancer Prev Res (Phila). 2019 Jul 26. pii: canprevres.0238.2019. doi: 10.1158/1940-6207.CAPR-19-0238. [Epub ahead of print]

PMID:
31350279
3.

Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype.

Noto JM, Zackular JP, Varga MG, Delgado A, Romero-Gallo J, Scholz MB, Piazuelo MB, Skaar EP, Peek RM Jr.

MBio. 2019 May 28;10(3). pii: e00955-19. doi: 10.1128/mBio.00955-19.

4.

Reply.

Butt J, Varga MG, Epplein M.

Gastroenterology. 2019 Jun;156(8):2356. doi: 10.1053/j.gastro.2019.04.040. Epub 2019 Apr 27. No abstract available.

PMID:
31039340
5.

Epstein-Barr virus, but not human cytomegalovirus, is associated with a high-grade human papillomavirus-associated cervical lesions among women in North Carolina.

Kienka T, Varga MG, Caves J, Smith JS, Sivaraman V.

J Med Virol. 2019 Mar;91(3):450-456. doi: 10.1002/jmv.25336. Epub 2018 Oct 31.

PMID:
30307626
6.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
7.

Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M.

Dig Dis Sci. 2018 Oct;63(10):2765-2772. doi: 10.1007/s10620-018-5154-9. Epub 2018 Jun 8.

PMID:
29948559
8.

Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China.

Varga MG, Wang T, Cai H, Xiang YB, Gao YT, Ji BT, Pawlita M, Waterboer T, Zheng W, Shu XO, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):342-344. doi: 10.1158/1055-9965.EPI-17-1084. Epub 2017 Dec 20.

9.

DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori.

Varga MG, Peek RM.

Curr Top Microbiol Immunol. 2017;400:169-193. doi: 10.1007/978-3-319-50520-6_8. Review.

10.

TLR9 activation suppresses inflammation in response to Helicobacter pylori infection.

Varga MG, Piazuelo MB, Romero-Gallo J, Delgado AG, Suarez G, Whitaker ME, Krishna US, Patel RV, Skaar EP, Wilson KT, Algood HM, Peek RM Jr.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G852-G858. doi: 10.1152/ajpgi.00175.2016. Epub 2016 Oct 6.

11.

Genetic Evolution of a Helicobacter pylori Acid-Sensing Histidine Kinase and Gastric Disease.

Krishna U, Romero-Gallo J, Suarez G, Azah A, Krezel AM, Varga MG, Forsyth MH, Peek RM Jr.

J Infect Dis. 2016 Aug 15;214(4):644-8. doi: 10.1093/infdis/jiw189. Epub 2016 May 10.

12.

Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system.

Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA, Good JA, Almqvist F, Skaar EP, Correa P, Wilson KT, Hadjifrangiskou M, Peek RM.

Oncogene. 2016 Dec 1;35(48):6262-6269. doi: 10.1038/onc.2016.158. Epub 2016 May 9.

13.

miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.

Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM, Araya JC, Roa JC.

Cell Oncol (Dordr). 2016 Feb;39(1):23-33. doi: 10.1007/s13402-015-0247-3. Epub 2015 Oct 12.

14.

Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection.

Noto MJ, Boyd KL, Burns WJ, Varga MG, Peek RM Jr, Skaar EP.

Infect Immun. 2015 Oct;83(10):4134-41. doi: 10.1128/IAI.00410-15. Epub 2015 Aug 3.

Supplemental Content

Loading ...
Support Center